☆ 4.7 Letter

Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2, Update Alert 3)

ANNALS OF INTERNAL MEDICINE (2022)

Related references

Note: Only part of the references are listed.

Article Public, Environmental & Occupational Health

Remdesivir Efficacy in COVID-19 Treatment: A Randomized Controlled Trial

Sherief Abd-Elsalam et al.

Summary: This study assessed the efficacy of Remdesivir in Egyptian patients with COVID-19 and found that it had a positive impact on the length of hospital stay but did not have a mortality benefit. Its use should be considered in addition to standard care when other effective options are limited.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2022)

Add to Collection

Review Medicine, General & Internal

Major Update 2: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points

Anjum S. Kaka et al.

Summary: This review updates the evidence on the use of Remdesivir for adult patients with COVID-19. The findings suggest that Remdesivir may not significantly reduce mortality but increases the proportion of recovered patients. It may reduce time to clinical improvement and decrease serious adverse events, but may increase any adverse events.

ANNALS OF INTERNAL MEDICINE (2022)

Add to Collection

Article Infectious Diseases

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader et al.

Summary: A study conducted in COVID-19 patients admitted to hospital and requiring oxygen support found that remdesivir did not show significant clinical benefits compared to standard care alone.

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Review Medicine, General & Internal

Remdesivir for Adults With COVID-19 A Living Systematic Review for American College of Physicians Practice Points

Timothy J. Wilt et al.

Summary: The study found that remdesivir may improve recovery and reduce mortality in severe COVID-19 patients compared to placebo. Among hospitalized patients, a 5-day course of remdesivir may provide similar benefits to a 10-day course with fewer side effects.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Update Alert 2: Remdesivir for Adults With COVID-19

Anjum S. Kaka et al.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Amir Qaseem et al.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results

Summary: The authors of the study reported the interim results of using four repurposed antiviral drugs (remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a) in hospitalized COVID-19 patients. The study showed that these drug regimens had little or no effect on overall mortality, initiation of ventilation, and duration of hospital stay.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Amir Qaseem et al.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Review Medicine, General & Internal

Major Update: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points

Anjum S. Kaka et al.

Summary: The study suggests that remdesivir may not significantly reduce mortality in COVID-19 patients, but it likely improves the percentage of patients who recover and reduces serious harms. It may also result in a small decrease in the proportion of patients needing ventilation.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

The Development of Living, Rapid Practice Points: Summary of Methods From the Scientific Medical Policy Committee of the American College of Physicians

Amir Qaseem et al.

Summary: The Scientific Medical Policy Committee (SMPC) of the American College of Physicians (ACP) aims to provide evidence-based clinical advice through rapid systematic review, use of the GRADE method, and strict policies on disclosure of interests, to address timely key questions for decision-making.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Update Alert: Remdesivir for Adults With COVID-19

Anjum S. Kaka et al.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Amir Qaseem et al.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 A Randomized Trial

Andreas Barratt-Due et al.

Summary: A randomized controlled trial conducted in 23 hospitals in Norway found that remdesivir and hydroxychloroquine did not affect viral clearance in hospitalized COVID-19 patients. There was also no impact on mortality, degree of respiratory failure, or inflammatory variables.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Jason D. Goldman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

© Peeref 2019-2024. All rights reserved.